<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03181165</url>
  </required_header>
  <id_info>
    <org_study_id>H16-01539</org_study_id>
    <nct_id>NCT03181165</nct_id>
  </id_info>
  <brief_title>Pharmacist-led Therapeutic Nutritional Intervention in Type 2 Diabetes</brief_title>
  <official_title>Impact of a Pharmacist-led Therapeutic Nutritional Intervention on Medications and Glucose Control in Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mitacs</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pharmasave</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 2 diabetes represents a significant burden to both the individual and our healthcare
      system. Individuals with type 2 diabetes are typically prescribed one or more
      glucose-lowering medications, many of which have undesirable side effects (e.g., nausea, risk
      of cardiovascular complications, weight gain) and cost our healthcare system a lot of money.
      An alternative strategy to lower blood glucose is to consume a low-carbohydrate diet.
      However, adjusting medications after choosing to follow a low-carbohydrate diet can be
      difficult. Delivering a low-carbohydrate diet through pharmacists could circumvent this
      difficulty in medications adjustment because pharmacists are trained to adjust medications.
      In this study the investigators will determine whether type 2 diabetes patients can reduce
      medications and improve blood glucose by following a low-carbohydrate, low-calorie diet under
      the direction of a pharmacist.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Pragmatic effectiveness trial of diet intervention led by community pharmacists versus treatment-as-usual waitlist control.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Participants will know group assignments</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants not on glucose-lowering medications</measure>
    <time_frame>12 weeks</time_frame>
    <description>Number of individuals taking no medications divided by the total number of participants.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1C</measure>
    <time_frame>12 weeks</time_frame>
    <description>Blood test to measure glucose control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in glucose-lowering medications</measure>
    <time_frame>12 weeks</time_frame>
    <description>Reduction in total dose of glucose-lowering medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body mass in kilograms divided by height in meters squared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>12 weeks</time_frame>
    <description>Waist circumference in centimeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat percentage</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body fat percentage measured by bioelectrical impedance analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body mass in kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>12 weeks</time_frame>
    <description>Short-form (SF)-20 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in non-glucose lowering medications</measure>
    <time_frame>12 weeks</time_frame>
    <description>Dose of medications other than glucose-lowering</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipid profile</measure>
    <time_frame>12 weeks</time_frame>
    <description>triglycerides, HDL and LDL cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting insulin</measure>
    <time_frame>12 weeks</time_frame>
    <description>Fasting insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting C-peptide</measure>
    <time_frame>12 weeks</time_frame>
    <description>fasting C-peptide</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>12 weeks</time_frame>
    <description>Fasting high-sensitivity C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver enzymes</measure>
    <time_frame>12 weeks</time_frame>
    <description>liver alanine amino transferase, aspartate aminotransferase, gamma-gluatmyl transpeptidase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting plasma glucose</measure>
    <time_frame>12 weeks</time_frame>
    <description>Fasting plasma glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>12 weeks</time_frame>
    <description>Systolic Blood Pressure measured by automatic cuff</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>12 weeks</time_frame>
    <description>Diastolic Blood Pressure measured by automatic cuff</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Habitual physical activity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Godin leisure-time exercise questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Energy intake</measure>
    <time_frame>Baseline, 6 weeks, and 12 weeks</time_frame>
    <description>3-day diet record</description>
  </other_outcome>
  <other_outcome>
    <measure>Macronutrient intake</measure>
    <time_frame>Baseline, 6 weeks, and 12 weeks</time_frame>
    <description>3-day diet record</description>
  </other_outcome>
  <other_outcome>
    <measure>Intervention Satisfaction</measure>
    <time_frame>12 weeks</time_frame>
    <description>Satisfaction with intervention delivery questionnaire</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Diet Modification</condition>
  <arm_group>
    <arm_group_label>Low-carbohydrate Therapeutic Nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 12-week low-carbohydrate, energy-restricted diet will be administered using a combination of pre-packaged foods and whole foods from pre-specified lists.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment-as-usual waitlist control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive standard lifestyle advice to follow a low-fat, low-sugar, high fibre diet and aim to accumulate 150 minutes of moderate activity per week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low-carbohydrate Therapeutic Nutrition</intervention_name>
    <description>The pharmacist or pharmacy lifestyle coach will work with the participant to develop a diet plan that is low in carbohydrate and energy-restricted based on personal preferences and characteristics. A combination of pre-packaged low-carbohydrate foods and whole foods from pre-specified lists will be used.</description>
    <arm_group_label>Low-carbohydrate Therapeutic Nutrition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Between the ages of 30 and 75, have type 2 diabetes mellitus diagnosed by a physician, are
        taking one or more glucose-lowering medications, have a BMI â‰¥30, have no contraindications
        to following low-carbohydrate, energy-restricted, high-protein diet, and can read and speak
        English.

        Exclusion Criteria:

        Exlcusion criteria are:

          1. Recent (within the last 2 years) diagnosis of coronary heart disease, stroke, or a
             heart attack.

          2. Unstable cardiovascular disorder.

          3. History of liver disease.

          4. History of kidney disease or impaired renal function.

          5. Previously undergone bariatric surgery.

          6. Multiple sclerosis or other diagnosed neurological disease.

          7. Currently pregnant or lactating, or planning on becoming pregnant in the next 12
             months.

          8. Any form of cancer within the last 5 years.

          9. Body mass index (BMI) of &lt;30.

         10. Dietary restrictions that do not allow you to follow a low-carbohydrate,
             energy-restricted, high-protein diet (e.g., vegan, food allergies).

         11. Any sensitivities to the ingredients in the pre-packaged foods
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan P Little, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonathan P Little, PhD</last_name>
    <phone>2508786893</phone>
    <email>jonathan.little@ubc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cody Durrer, MSc</last_name>
    <phone>2504702479</phone>
    <email>therapeutic.nutrition@ubc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of British Columbia</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <zip>V1V1V7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Little, PhD</last_name>
      <phone>2508079876</phone>
      <email>jonathan.little@ubc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Cody Durrer, MSc</last_name>
      <phone>2508079122</phone>
      <email>cdurrer@live.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2017</study_first_submitted>
  <study_first_submitted_qc>June 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>August 1, 2017</last_update_submitted>
  <last_update_submitted_qc>August 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Jonathan Little</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Low-carbohydrate</keyword>
  <keyword>Low calorie</keyword>
  <keyword>Energy restricted</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual values will be reported in figures if applicable.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

